← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2019-1:151 | 151 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:151 | 151 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2600 | 72627-2600-5 | Benzyl Alcohol | 2019-2 | valid | 0 | 2026-10-13 | |
outsourcing:2020-1:151 | 151 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-1821 | 72907-1821-3 | Betamethasone Sodium Phosphate | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:151 | 151 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:151 | 151 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8005 | 71266-8005-2 | Bevacizumab | 2021-1 | valid | 0 | 2026-10-13 | |
outsourcing:2021-2:151 | 151 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-091 | 71449-091-44 | Bevacizumab | 2021-2 | valid | 0 | 2026-10-13 | |
outsourcing:2022-1:151 | 151 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2022-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-2:151 | 151 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Calcium Chloride | 2022-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-1:151 | 151 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2023-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-2:151 | 151 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4344 | 72934-4344-8 | Betamethasone Dipropionate; Minoxidil; Niacinamide; Pentoxifylline | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:151 | 151 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bromfenac Sodium; Prednisolone Acetate | 2024-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-2:151 | 151 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0206 | 72196-0206-1 | Calcium Chloride; Sodium Chloride; Potassium Chloride; Mannitol; Lidocaine Hydrochloride; Sodium Bicarbonate | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:151 | 151 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0206 | 71285-0206-1 | Calcium Chloride; Sodium Chloride; Potassium Chloride; Mannitol; Lidocaine Hydrochloride; Sodium Bicarbonate | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:151 | 151 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-138 | 69194-138-01 | Bupivacaine Hydrochloride; Lidocaine Hydrochloride | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:151 | 151 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5500 | 26436-5500-1 | Buprenorphine Hydrochloride | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:152 | 152 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9004 | 83826-9004-1 | Dexamethasone phosphate, Moxiflocacin HCl | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:152 | 152 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:152 | 152 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-216 | 69852-216-10 | Betamethasone Acetate; Betamethasone Sodium Phosphate | 2019-2 | valid | 0 | 2026-10-13 | |
outsourcing:2020-1:152 | 152 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-1015 | 71266-1015-1 | Betamethasone Sodium Phosphate | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:152 | 152 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:152 | 152 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:152 | 152 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-091 | 71449-091-98 | Bevacizumab | 2021-2 | valid | 0 | 2026-10-13 | |
outsourcing:2022-1:152 | 152 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2022-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-2:152 | 152 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-064 | 73198-064-30 | Calcium Chloride Anhydrous | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:152 | 152 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-091 | 71449-091-98 | Bevacizumab | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:152 | 152 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-1821 | 72907-1821-3 | Betamethasone Sodium Phosphate | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:152 | 152 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-881 | 69852-881-10 | Brompheniramine Maleate | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:152 | 152 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0206 | 71285-0206-1 | Calcium Chloride; Sodium Chloride; Potassium Chloride; Mannitol; Lidocaine Hydrochloride; Sodium Bicarbonate | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:152 | 152 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Calcium Gluconate | 2025-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2025-2:152 | 152 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5500 | 26436-5500-1 | Buprenorphine Hydrochloride | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:152 | 152 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4618 | 72934-4618-3 | Calcipotriene; Clobetasol Propionate | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:153 | 153 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-110 | 73177-110-12 | Lidocaine Hydrochloride | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:153 | 153 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:153 | 153 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Betamethasone Acetate; Betamethasone Sodium Phosphate | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:153 | 153 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-3284 | 62295-3284-7 | Betamethasone Sodium Phosphate; Betamethasone Acetate | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:153 | 153 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:153 | 153 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:153 | 153 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-091 | 71449-091-43 | Bevacizumab | 2021-2 | valid | 0 | 2026-10-13 | |
outsourcing:2022-1:153 | 153 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-106 | 63037-106-05 | Bupivacaine Hydrochloride; Fentanyl Citrate | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:153 | 153 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0206 | 71285-0206-1 | Calcium Chloride; Sodium Chloride; Potassium Chloride; Mannitol; Lidocaine Hydrochloride; Sodium Bicarbonate | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:153 | 153 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-091 | 71449-091-43 | Bevacizumab | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:153 | 153 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-1025 | 71266-1025-1 | Betamethasone Sodium Phosphate | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:153 | 153 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71791-0101 | 71791-0101-1 | Brompheniramine Maleate | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:153 | 153 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Calcium Gluconate | 2024-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2025-1:153 | 153 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-392 | 69194-392-01 | Calcium Gluconate | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:153 | 153 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4618 | 72934-4618-3 | Calcipotriene; Clobetasol Propionate | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:153 | 153 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-625 | 69194-625-01 | Calcium Chloride | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:154 | 154 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0081 | 70168-0081-1 | Testo87.5mgCHOL | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:154 | 154 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-040 | 70004-040-06 | Atropine Sulfate | 2019-1 | valid | 0 | 2026-10-13 | |
outsourcing:2019-2:154 | 154 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-1015 | 71266-1015-2 | Betamethasone Sodium Phosphate | 2019-2 | valid | 0 | 2026-10-13 | |
outsourcing:2020-1:154 | 154 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-4795 | 61141-4795-2 | Betamethasone Sodium Phosphate; Betamethasone Acetate | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:154 | 154 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:154 | 154 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:154 | 154 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8006 | 71266-8006-1 | Bevacizumab | 2021-2 | valid | 0 | 2026-10-13 | |
outsourcing:2022-1:154 | 154 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-109 | 63037-109-05 | Bupivacaine Hydrochloride; Fentanyl Citrate | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:154 | 154 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-950 | 69374-950-10 | Calcium Gluconate | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:154 | 154 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-091 | 71449-091-44 | Bevacizumab | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:154 | 154 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-1025 | 71266-1025-2 | Betamethasone Sodium Phosphate | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:154 | 154 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9160 | 71266-9160-2 | Bupivacaine Hydrochloride | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:154 | 154 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Calcium Gluconate | 2024-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2025-1:154 | 154 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-134 | 69194-134-01 | Calcium Gluconate | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:154 | 154 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-210 | 69194-210-01 | Calcium Chloride | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:154 | 154 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-210 | 69194-210-01 | Calcium Chloride | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:155 | 155 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-164 | 82396-164-13 | Oxycodone Hydrochloride | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:155 | 155 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-040 | 70004-040-07 | Atropine Sulfate | 2019-1 | valid | 0 | 2026-10-13 | |
outsourcing:2019-2:155 | 155 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-1015 | 71266-1015-1 | Betamethasone Sodium Phosphate | 2019-2 | valid | 0 | 2026-10-13 | |
outsourcing:2020-1:155 | 155 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2020-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-2:155 | 155 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72833-589 | 72833-589-30 | Biotin | 2020-2 | valid | 0 | 2026-10-13 | |
outsourcing:2021-1:155 | 155 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:155 | 155 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1661 | 5446-1661-13 | Bevacizumab | 2021-2 | valid | 0 | 2026-10-13 | |
outsourcing:2022-1:155 | 155 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Lidocaine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-2:155 | 155 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Calcium Gluconate | 2022-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-1:155 | 155 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2023-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-2:155 | 155 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2023-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-1:155 | 155 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-2:155 | 155 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5005 | 26436-5005-2 | Calcium Gluconate Monohydrate | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:155 | 155 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0418 | 71285-0418-1 | Calcium Gluconate Monohydrate; Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:155 | 155 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-625 | 69194-625-01 | Calcium Chloride | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:155 | 155 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-064 | 73198-064-30 | Calcium Chloride | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:156 | 156 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 83556-0510 | 83556-0510-2 | Vancomycin 10mg/mL | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:156 | 156 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:156 | 156 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-1821 | 72907-1821-3 | Betamethasone Sodium Phosphate | 2019-2 | valid | 0 | 2026-10-13 | |
outsourcing:2020-1:156 | 156 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8005 | 71266-8005-2 | Bevacizumab | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:156 | 156 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Brolucizumab | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:156 | 156 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:156 | 156 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:156 | 156 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Lidocaine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-2:156 | 156 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Calcium Gluconate | 2022-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-1:156 | 156 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2023-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-2:156 | 156 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2023-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-1:156 | 156 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-269 | 70092-269-37 | Bupivacaine Hydrochloride Anhydrous; Fentanyl Citrate | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:156 | 156 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0418 | 71285-0418-1 | Calcium Gluconate Monohydrate; Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:156 | 156 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0416 | 71285-0416-1 | Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Valine; Heparin Sodium | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:156 | 156 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Calcium Chloride | 2025-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2026-1:156 | 156 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0206 | 72196-0206-1 | Calcium Chloride; Sodium Chloride; Potassium Chloride; Mannitol; Lidocaine Hydrochloride; Sodium Bicarbonate | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:157 | 157 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-657 | 70092-657-76 | Ropivacaine PF 0.2% 250ml NS CADD-B FSFF | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:157 | 157 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:157 | 157 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-3284 | 62295-3284-7 | Betamethasone Sodium Phosphate; Betamethasone Acetate | 2019-2 | valid | 0 | 2026-10-13 | |
outsourcing:2020-1:157 | 157 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-091 | 71449-091-43 | Bevacizumab | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:157 | 157 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Brolucizumab | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:157 | 157 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:157 | 157 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:157 | 157 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Calcium Chloride | 2022-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-2:157 | 157 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Calcium Gluconate | 2022-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-1:157 | 157 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8006 | 71266-8006-1 | Bevacizumab | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:157 | 157 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0041 | 81483-0041-5 | Bevacizumab | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:157 | 157 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0036 | 81483-0036-0 | Bupivacaine Hydrochloride; Epinephrine Bitartrate | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:157 | 157 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0422 | 72196-0422-1 | Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium; Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:157 | 157 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0422 | 72196-0422-1 | Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium; Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:157 | 157 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0206 | 71285-0206-1 | Calcium Chloride; Sodium Chloride; Potassium Chloride; Mannitol; Lidocaine Hydrochloride; Sodium Bicarbonate | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:157 | 157 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0206 | 71285-0206-1 | Calcium Chloride; Sodium Chloride; Potassium Chloride; Mannitol; Lidocaine Hydrochloride; Sodium Bicarbonate | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:158 | 158 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0060 | 70168-0060-1 | Testo70mg | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:158 | 158 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-015 | 71449-015-06 | Atropine Sulfate | 2019-1 | valid | 0 | 2026-10-13 | |
outsourcing:2019-2:158 | 158 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-4795 | 61141-4795-2 | Betamethasone Sodium Phosphate; Betamethasone Acetate | 2019-2 | valid | 0 | 2026-10-13 | |
outsourcing:2020-1:158 | 158 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-091 | 71449-091-35 | Bevacizumab | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:158 | 158 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bromfenac Sodium; Prednisolone Acetate | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:158 | 158 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:158 | 158 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:158 | 158 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Calcium Chloride Anhydrous | 2022-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-2:158 | 158 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-021 | 71506-021-56 | Calcium Gluconate | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:158 | 158 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2023-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-2:158 | 158 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2023-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-1:158 | 158 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-4837 | 61141-4837-1 | Bupivacaine Hydrochloride; Fentanyl Citrate | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:158 | 158 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-9410 | 72934-9410-1 | Cantharidin; Podophyllum Resin; Salicylic Acid | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:158 | 158 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-9542 | 72934-9542-1 | Cantharidin; Podophyllum Resin; Salicylic Acid | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:158 | 158 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0206 | 72196-0206-1 | Calcium Chloride; Sodium Chloride; Potassium Chloride; Mannitol; Lidocaine Hydrochloride; Sodium Bicarbonate | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:158 | 158 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-134 | 69194-134-01 | Calcium Gluconate | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:159 | 159 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0101 | 70168-0101-1 | Testo100mgCHOL | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:159 | 159 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:159 | 159 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:159 | 159 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-091 | 71449-091-44 | Bevacizumab | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:159 | 159 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bromfenac Sodium; Prednisolone Acetate; Moxifloxacin Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:159 | 159 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:159 | 159 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72833-589 | 72833-589-30 | Biotin | 2021-2 | valid | 0 | 2026-10-13 | |
outsourcing:2022-1:159 | 159 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0206 | 71285-0206-1 | Calcium Chloride; Sodium Chloride; Potassium Chloride; Mannitol; Lidocaine Hydrochloride; Sodium Bicarbonate | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:159 | 159 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-020 | 71506-020-56 | Calcium Gluconate | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:159 | 159 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2023-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-2:159 | 159 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2023-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-1:159 | 159 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1014 | 73013-1014-1 | Bupivacaine Hydrochloride; Fentanyl Citrate | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:159 | 159 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-0649 | 26436-0649-3 | Carnitine | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:159 | 159 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-0649 | 26436-0649-3 | Carnitine | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:159 | 159 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-392 | 69194-392-01 | Calcium Gluconate | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:159 | 159 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-395 | 69194-395-01 | Calcium Gluconate | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:160 | 160 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0006 | 73271-0006-1 | ESTRADIOL 6 PEL | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:160 | 160 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69623-131 | 69623-131-12 | Atropine Sulfate Anhydrous | 2019-1 | valid | 0 | 2026-10-13 | |
outsourcing:2019-2:160 | 160 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:160 | 160 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70731-197 | 70731-197-93 | Bevacizumab | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:160 | 160 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bromfenac Sodium; Prednisolone Acetate; Moxifloxacin Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:160 | 160 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:160 | 160 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2435 | 72627-2435-2 | Biotin | 2021-2 | valid | 0 | 2026-10-13 | |
outsourcing:2022-1:160 | 160 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6019 | 72196-6019-1 | Calcium Gluconate | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:160 | 160 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0014 | 81483-0014-0 | Calcium Gluconate | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:160 | 160 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bimatoprost; Timolol Maleate | 2023-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-2:160 | 160 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-091 | 71449-091-44 | Bevacizumab | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:160 | 160 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2024-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-2:160 | 160 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70214-2011 | 70214-2011-1 | Cefazolin | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:160 | 160 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-131 | 73702-131-10 | Cefazolin | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:160 | 160 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-134 | 69194-134-01 | Calcium Gluconate | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:160 | 160 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-392 | 69194-392-01 | Calcium Gluconate | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:161 | 161 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 79559-3020 | 79559-3020-1 | S-E020 | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:161 | 161 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:161 | 161 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:161 | 161 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2020-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-2:161 | 161 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-3319 | 62295-3319-7 | Brompheniramine Maleate | 2020-2 | valid | 0 | 2026-10-13 | |
outsourcing:2021-1:161 | 161 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:161 | 161 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Brolucizumab | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:161 | 161 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6118 | 72196-6118-1 | Calcium Gluconate | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:161 | 161 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0418 | 71285-0418-1 | Calcium Gluconate Monohydrate; Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:161 | 161 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-087 | 73198-087-10 | Biotin | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:161 | 161 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-091 | 71449-091-22 | Bevacizumab | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:161 | 161 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2024-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-2:161 | 161 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70214-2013 | 70214-2013-1 | Cefazolin | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:161 | 161 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-132 | 73702-132-23 | Cefazolin | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:161 | 161 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-395 | 69194-395-01 | Calcium Gluconate | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:161 | 161 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-6003 | 26436-6003-2 | Calcium Gluconate | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:162 | 162 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-134 | 73702-134-15 | Succinylcholine Chloride | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:162 | 162 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:162 | 162 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:162 | 162 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2020-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-2:162 | 162 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Budesonide | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:162 | 162 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:162 | 162 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Brolucizumab | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:162 | 162 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6018 | 72196-6018-1 | Calcium Gluconate | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:162 | 162 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0416 | 71285-0416-1 | Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Valine; Heparin Sodium | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:162 | 162 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2435 | 72627-2435-2 | Biotin | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:162 | 162 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-091 | 71449-091-43 | Bevacizumab | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:162 | 162 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2024-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-2:162 | 162 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70214-2012 | 70214-2012-1 | Cefazolin | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:162 | 162 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-132 | 73702-132-10 | Cefazolin | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:162 | 162 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-145 | 69194-145-01 | Calcium Gluconate | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:162 | 162 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-153 | 69194-153-01 | Calcium Gluconate Monohydrate | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:163 | 163 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6064 | 71285-6064-1 | Vancomycin 1gm added to NS | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:163 | 163 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:163 | 163 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:163 | 163 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2020-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-2:163 | 163 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Budesonide | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:163 | 163 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:163 | 163 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bromfenac Sodium; Prednisolone Acetate | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:163 | 163 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-020 | 71506-020-56 | Calcium Gluconate | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:163 | 163 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0422 | 72196-0422-1 | Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium; Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate | 2022-2 | valid | 0 | 2026-10-13 |